Keywords: آگونیست β2 کوتاه مدت; Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
مقالات ISI آگونیست β2 کوتاه مدت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آگونیست β2 کوتاه مدت; Adult asthma; Airway hyperresponsiveness; Asthma management; ICS; Step-down; Innate immunity; Regulatory T cell; IL-10; IL-33; ACh; Acetylcholine dichloride; Feno; Fractional exhaled nitric oxide; GINA; Global Initiative for Asthma; Hist; Histamine dihydr
Keywords: آگونیست β2 کوتاه مدت; Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
Keywords: آگونیست β2 کوتاه مدت; Chinese herbal medicine formula; Acute asthma; Randomized controlled trial; Inflammatory cytokines; Proof-of-concept; ASHMI; antiasthma simplified herbal medicine intervention; CRP; C-reactive protein; ELISA; enzyme - linked immunosorbent assay; ERS; Euro
Keywords: آگونیست β2 کوتاه مدت; The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
Keywords: آگونیست β2 کوتاه مدت; Biologic therapy; Comorbidities; Adherence; Inhaled corticosteroid; Phenotype; Severe asthma; ABPA; Allergic bronchopulmonary aspergillosis; AERD; Aspirin-exacerbated respiratory disease; COPD; Chronic obstructive pulmonary disease; CRS; Chronic rhinosinu
Keywords: آگونیست β2 کوتاه مدت; Asthma; Asthma exacerbation; Viral infection; Allergy; Prevention; Treatment; Inhaled corticosteroids; Long-acting β2-agonists; Leukotriene antagonist; Anticholinergics; Anti-IgE; Anti-IL5; Systemic corticosteroids; ED; Emergency department; FEV1; Forced
Keywords: آگونیست β2 کوتاه مدت; Administrative data; Corticosteroid; Comorbidities; Allergist; Asthma specialist; Asthma control; Blood eosinophil count; Chronic oral corticosteroid use; Controller medication; Exacerbations; Asthma guidelines; Managed care; Persistent asthma; Short-acti
Keywords: آگونیست β2 کوتاه مدت; Asthma; asthma control; budesonide/formoterol maintenance and reliever therapy; exacerbations; Global Initiative for Asthma; predictors; risk score; ACQ-5; 5-Item Asthma Control Questionnaire; ADAS; Asthma Disease Activity Score; BMI; Body mass index; BUD
Keywords: آگونیست β2 کوتاه مدت; Asthma; health care; insurance claim review; pregnancy; ED; Emergency department; ICD-10; International Classification of Diseases, 10th revision; ICS; Inhaled corticosteroid; ICU; Intensive care unit; LABA; Long-acting β2-agonist; NHI; National Health I
Keywords: آگونیست β2 کوتاه مدت; Asthma; Childhood; Small-particle beclomethasone; Fluticasone; Inhaled corticosteroid; Long-acting β2-agonist; Step-up therapy; adjOR; adjusted odds ratio; adjRR; adjusted rate ratio; GP; general practice; ICS; inhaled corticosteroid; LABA; long-acting Î
Keywords: آگونیست β2 کوتاه مدت; asthma; Severe asthma; Asthma control; Asthma management; Prescription data; ACE; Angiotensin-converting-enzyme; COPD; Chronic obstructive pulmonary disease; ED; Emergency department; GP; General practitioner; ICS; Inhaled corticosteroid; ICS-LABA; Fixed-
Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA
Keywords: آگونیست β2 کوتاه مدت; Combination therapy; COPD; Inhaled corticosteroids; Long-acting bronchodilators; LAMA/LABA; Fixed-dose dual bronchodilators; CDS; Chronic Disease Score; CI; confidence interval; COPD; chronic obstructive pulmonary disease; ER; emergency room; FDC; fixed-d
Daily variation in lung function in COPD patients with combined albuterol and ipratropium: Results from a 4-week, randomized, crossover study
Keywords: آگونیست β2 کوتاه مدت; Bronchodilator; COPD; Short-acting β2-agonist; Short-acting muscarinic antagonist;
Risk of congenital malformations for asthmatic pregnant women using a long-acting β2-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy
Keywords: آگونیست β2 کوتاه مدت; Asthma; pregnancy; congenital malformations; inhaled corticosteroid; long-acting β2-agonist; combination therapy; high-dose inhaled corticosteroid; cohort study; comparative safety study; administrative health databases; ICD-9; International Classificati
Sports doping: Emerging designer and therapeutic β2-agonists
Keywords: آگونیست β2 کوتاه مدت; AAF; adverse analytical finding; CAS; Court of Arbitration for Sport; COMT; Catechol-O-MethylTransferase; COPD; Chronic Obstructive Pulmonary Disease; ELISA; Enzyme-Linked Immunosorbent Assay; EU; European Union; FDA; Food and Drug Administration; HP-TLC;
Severe Asthma: An Expanding and Mounting Clinical Challenge
Keywords: آگونیست β2 کوتاه مدت; Asthma; corticosteroids; bronchodilators; immunomodulators; anti-IgE; ABPA; Allergic bronchopulmonary aspergillosis; ATS; American Thoracic Society; EMTU; Epithelial mesangial trophic unit; ENFUMOSA; European Network For Understanding Mechanisms Of Severe
The Role of the Primary Care Physician in Helping Adolescent and Adult Patients Improve Asthma Control
Keywords: آگونیست β2 کوتاه مدت; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; Asthma APGAR; Asthma Activity limitation/Persistence of symptoms/Triggers/Asthma medications/Response to therapy tool; ATAQ; Asthma Therapy Assessment Questionnaire; FEV1; forced expiratory volu
Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting β2-agonists
Keywords: آگونیست β2 کوتاه مدت; Adrenergic β-agonists; asthma; cardiovascular system; epidemiology; lung diseases; obstructive; BMI; Body mass index; CATI; Computer-assisted telephone interview; CHD; Coronary heart disease; COPD; Chronic obstructive pulmonary disease; CVD; Cardiovascul
Patterns of asthma control: A 3-year analysis of patient claims
Keywords: آگونیست β2 کوتاه مدت; Asthma; asthma control; administrative claims; asthma variability; controller medications; ED; Emergency department; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; OCS; Oral corticosteroid; SABA; Short-acting β2-agonist;